Against cholesterol, least of statins in Europe

udra/epictura

Published the 03.01.2018 at 08h05

A A

Keywords :

cholestérolLDLstatineprévention primary

Researchers from Copenhagen University Hospital compared the usefulness of five recommendations published since 2013 on the primary prevention of cardiovascular disease, it is prevention before the occurrence of a first cardiovascular event in the context of hypercholesterolemia.
Although they are based on the same epidemiological data, these five recommendations have substantial differences. In particular regarding the prediction model recommended for cardiovascular disease, the risk threshold as well as the prescription of statins against the elevation of LDL-cholesterol.
This study is published in the journal Annals of Internal Medicine.

Europe stands out

The researchers conducted an observational study of cardiovascular events actual for 10 years. Subsequently, they worked on a modelling to estimate the effectiveness of different recommendations on 45 750 people aged 40 to 75 years who did not use statins and did not have cardiovascular disease.
The study shows that the percentage of people eligible for statins is 44% according to the recommendations of the Canadian Society of Cardiology, 42% for the American College of Cardiology (ACC), and only 15% for the european societies of cardiology and atherosclerosis (ESC and EAS).
Estimated percentage of cardiovascular diseases which could be prevented by using statins for 10 years is 34% for the canadians, 34% for the ACC, and only 13% for europeans.

It is clear that in Europe there is a suspicion of the sick on the actual benefit of the treatment against the cholesterol. A negative opinion that influences the way in which the experts analyze scientific data…or, these same experts insist more on the dietary approach.